We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ACRV market cap is 212.84M. The company's latest EPS is USD -2.7209 and P/E is -3.52.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.58M | -9.95M | -14.39M | -15.52M | -16.14M |
| Net Income | -9.2M | -8.93M | -12.76M | -13.91M | -14.47M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -16.18M | -32.66M | -67.1M |
| Net Income | -16.24M | -31.17M | -60.39M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 87.71M | 181.23M | 170.2M | 160.05M | 151.09M |
| Total Liabilities | 10.81M | 10.75M | 9.73M | 10.87M | 12.94M |
| Total Equity | -45.62M | 170.48M | 160.47M | 149.18M | 138.15M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 106.59M | 181.23M | 138.27M |
| Total Liabilities | 7.88M | 10.75M | 17.07M |
| Total Equity | -23.81M | 170.48M | 121.2M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -20.76M | -30.12M | -11.36M | -20.47M | -30.28M |
| Investing | -46.61M | -141.68M | 9.33M | 28.67M | 30.18M |
| Financing | -151k | 101.71M | N/A | 379k | 457k |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.98M | -30.12M | -42.64M |
| Investing | -238k | -141.68M | 50.72M |
| Financing | 112.22M | 101.71M | -1.55M |
| Market Cap | 212.84M |
| Price to Earnings Ratio | -3.52 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.9 |
| Price to Book Ratio | 1.75 |
| Dividend Yield | - |
| Shares Outstanding | 22.19M |
| Average Volume (1 week) | 219.62k |
| Average Volume (1 Month) | 2.23M |
| 52 Week Change | -27.29% |
| 52 Week High | 14.30 |
| 52 Week Low | 3.19 |
| Spread (Intraday) | 0.7 (7.02%) |
| Company Name | Acrivon Therapeutics Inc |
| Address |
838 walker road dover, delaware 19904 |
| Website | https://www.acrivon.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
